Drugs / retinal pigment epithelium transplantation
retinal pigment epithelium transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02755428 | Jan 2018 → Jan 2019 | dry age related macular degeneration | Chinese Academy of Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | retinal pigment epithelium transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02755428 ↗ |
| Modality | Cell therapy | “transplantation of human embryonic stem cell derived retinal pigment epitheliums” NCT02755428 ↗ |
| Route | Other | “into subretinal space” NCT02755428 ↗ |